|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.240 HKD | +0.42% |
|
0.00% | -14.12% |
| 06-11 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 06-11 | Alphamab Says Phase 3 Study of Breast Cancer Drug Meets Primary Endpoint | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 7.69 | 8.48 | 8.98 |
| Spread/Res. | -5.85% | -14.62% | -19.38% |
| Spread/Supp. | +4.02% | +4.02% | +16.59% |
| Support | 6.96 | 6.96 | 6.21 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 1093 Stock
- Charts CSPC Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
